Compare Injective (INJ) vs Chainlink (LINK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Injective vs Chainlink — how do they compare? Injective trades at Rp92,485 (market cap Rp9,26T, Rp1,73T 24h volume), while Chainlink trades at Rp154,256 (market cap Rp115,86T, Rp5,3T 24h volume). The key difference: Chainlink is far larger — about 12.5× Injective's market cap, and Chainlink's supply is capped (748,1M / 1B LINK (75%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Chainlink for 62 Days on average.
| INJ | LINK | |
|---|---|---|
Market Cap | Rp9,26T | Rp115,86T |
Volume (24h) | Rp1,73T | Rp5,3T |
Circulating Supply | 100M INJ | 748,1M / 1B LINK (75%) |
Typical Hold Time | 36 Days | 62 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
Chainlink (LINK) is trading at Rp154,227 with a market cap of Rp115.16T, showing bullish technical signals with 13 buy indicators versus 8 sells. The token is approaching resistance at Rp154,677 while maintaining support above Rp145,194. Recent news highlights Chainlink's role in blockchain interoperability and positive institutional sentiment, though RSI levels suggest potential overbought conditions.
Overall outlook remains cautiously optimistic with strong technical momentum but faces near-term resistance challenges. Key opportunities include growing adoption as a blockchain oracle solution, while risks involve regulatory uncertainty and technical overbought signals. Investors should monitor support levels and broader crypto market sentiment.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →About Chainlink
Founded in 2017 by Sergey Nazarov , Chainlink is a blockchain abstraction layer that enables universally connected smart contracts. Through a decentralized oracle network, Chainlink allows blockchains to securely interact with external data feeds, events and payment methods, providing the critical off-chain information needed by complex smart contracts to become the dominant form of digital agreement.
Read more on LINK →
